Awaiting development: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Type

Guidance programme

Guidance programme

HealthTech approach

HealthTech approach

Area of interest

Showing 391 to 391 of 391

TitleType
Zongertinib for treating HER2-mutated unresectable or metastatic non-small-cell lung cancer [ID6573]Technology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All